Chaga Capsules Research: What the Studies Tested and What the Label Says

Mushroom capsules are supplements taken in capsule form. Their ingredients, serving sizes and sweeteners vary by product. Pilly Labs currently sells one: Chaga Mushroom Complex, a single-ingredient Chaga capsule that lists its amount and standardization on the label. There is nothing to choose between within this category today; the real choice is capsule versus gummy, drop or coffee, which turns on whether you want a stated single-ingredient amount, how you prefer to take it, and your safety questions. Research below is context about Chaga, not a promise about this product.

Label facts are as published on the Pilly Labs product page on 2026-10-08, which attributes them to an owner-provided physical label. The bottle you receive is the final authority.

What's in each product

The 400 mg figure is the label's 40% applied to 1,000 mg. The label does not name which polysaccharides are measured or the test method. No sweetener is listed, but we do not call it "sugar-free" because that status is not stated on the label.

What the research says about Chaga

Laboratory evidence

Evidence type: laboratory study. A 2018 study measured three compounds (betulin, betulinic acid and inotodiol) in Chaga from France, Canada and Ukraine, then tested an aqueous Chaga extract on cultured human lung-derived cell lines (PMID 29484963).

What this does not show: results in cultured cells are not results in people. The material was an aqueous extract of Chaga growing on trees, not a mycelium powder, and polysaccharides were not the compounds measured. It does not show any benefit from the Pilly capsule.

Safety evidence: oxalates and the kidney

Evidence type: a single case report. A 2014 report described a 72-year-old woman who ate 4 to 5 teaspoons of Chaga powder a day for six months and developed oxalate-related kidney injury; the authors note that Chaga contains very high oxalate concentrations (PMID 23149251).

What this does not show: one case cannot establish how common the problem is, and her intake was a large amount of powder, not a labeled capsule serving. It is a reason for people with kidney stone or oxalate history to ask a clinician, not a conclusion about this product in either direction.

Where human evidence stands

The two primary sources we cite for Chaga are the laboratory study and the case report above. We have not located human trials to cite, so this page makes no statement about what Chaga does in people. Species and form also matter: studies vary in extraction method, mycelium versus fruiting body, dose, schedule and population, so a result from one preparation does not carry over to another.

For wider context on how to read label terms such as standardization and 10:1 extracts, see the Pilly Labs label guide, research standards and the research library.

How to choose a capsule, or another format

• You want a capsule with a stated Chaga amount: Chaga Mushroom Complex lists 1,000 mg and a 40% polysaccharide standardization. The form is mycelium, which differs from a fruiting-body extract.
• You want to avoid added sugar or sweeteners: the capsule lists none. The drops list stevia and gummies may contain sugar-based ingredients, so compare labels.
• You want Chaga alongside other mushrooms: Chaga is also named in the 10-Mushroom Gummies blend, two drop complexes and both coffees. The individual species shares are not stated for the gummy blend and the drop complexes. Vitality Coffee lists 5% Chaga powder, or 500 mg of Chaga per 10 g serving.
• You would rather not swallow capsules: use a different format; a capsule is not better, only different.

Several products contain Chaga. Ask a clinician before combining them, since some species amounts are undisclosed.

Safety and who should check with a clinician

• Ask a clinician first if you are pregnant or nursing, under 18, or have a medical condition.
• If you take anticoagulant or blood-thinning medication (such as warfarin or heparin), the product page advises asking a provider before use because Chaga may interact.
• The same advice applies if you take medication for blood sugar management.
• Chaga contains oxalates. People with a history of kidney stones or oxalate-related conditions, or kidney disease, should ask a clinician first.
• Do not use with a known mushroom allergy. Stop use and seek advice if you have an adverse reaction.

Frequently asked questions

Capsules vs gummies: which is better?

Neither in general. Capsules suit people who want a single stated ingredient and no sweeteners; gummies suit people who prefer a chewable. Compare the amounts on each label.

What does "standardized to 40% polysaccharides" mean?

It means the label states that 40% of the 1,000 mg is polysaccharides, which works out to 400 mg per serving. The label does not say how it was tested, and the number is not a measure of effect.

Is mycelium the same as fruiting body?

They are different forms, and Pilly Labs notes that studies vary in form (mycelium versus fruiting body), extraction method, dose and population. This product's label names mycelium powder, so a study on another Chaga preparation may not apply.

How do I take the capsules?

Pilly Labs directs 2 capsules daily with water, with or without food, morning or evening, and says to follow the bottle.

Why does the page mention kidney stones?

Chaga contains oxalates, and a published case report linked large amounts of Chaga powder to kidney injury. People with kidney stone history should check with a clinician before any Chaga product.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.